Desacetylcinobufagin
CAS No. 4026-95-3
Desacetylcinobufagin ( Deacetylcinobufagin )
Catalog No. M21666 CAS No. 4026-95-3
Deacetylcinobufagin a natural product shows potent activities against Hela and A375 cells in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 115 | Get Quote |
|
10MG | 171 | Get Quote |
|
25MG | 286 | Get Quote |
|
50MG | 422 | Get Quote |
|
100MG | 620 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDesacetylcinobufagin
-
NoteResearch use only not for human use.
-
Brief DescriptionDeacetylcinobufagin a natural product shows potent activities against Hela and A375 cells in vitro.
-
DescriptionDeacetylcinobufagin a natural product shows potent activities against Hela and A375 cells in vitro.
-
SynonymsDeacetylcinobufagin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4026-95-3
-
Formula Weight400.51
-
Molecular FormulaC24H30O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥25 mg/mL (62.42 mM)
-
SMILESC[C@]([C@@H](C(C=C1)=COC1=O)[C@]2O)(CC[C@@]3([H])[C@@]4([H])CC[C@@]5([H])[C@@]3(CC[C@](O)C5)C)[C@@]64[C@@H]2O6
-
Chemical Name3-beta16-beta-Dihydroxy-1415-beta-epoxy-5-beta-bufa-2022-dienolide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xiao-Chi Ma et al. Efficient Isolation and Purification of Five Products From Microbial Biotransformation of Cinobufagin by High-Speed Counter-Current Chromatography. J Sep Sci 33 (15) 2272-7
molnova catalog
related products
-
Jujuboside B
Jujuboside B has potent inhibitory effects on collagen-, thrombin-, AA-, and ADP-induced aggregation, and also exhibits superior protection on the thromboembolic model.
-
7-Acetyllycopsamine
Lycopsamine `1-acetate is a bioactive chemical.
-
AD 01
FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration as well as tubule and microvessel formation in vitro and in vivo. Blocks tumor growth in xenograft models.